NATROX® Symposium at EWMA 2018

NATROX® Symposium at EWMA 2018

Inotec AMD hosted a well-attended symposium at the 2018 EWMA Conference in Krakow (Poland).

The Symposium focused on the vital role of oxygen in chronic wound healing and the importance of the Inotec’s NATROX® Oxygen Wound Therapy supported by three key speakers of the calibre of Paul Hayes, Hanna Kaufman and Thomas Serena.

Paul Hayes, vascular surgeon from the UK, discussed the role of topical oxygen in wound healing presenting the latest evidence on the matter. Hanna Kaufman, orthopaedic surgeon from Israel, shared the intriguing results of her 99-patient NATROX® study on non-healing wounds. Thomas Serena, founder and medical director of SerenaGroup in the US, explored the future of oxygen wound therapy.

NATROX® Oxygen Wound Therapy is an innovative, simple and easy-to-use device that has been clinically proven to deliver 98% pure humidified oxygen direct to the wound bed.

Figure 1 Thomas Serena (left), Hanna Kaufman (middle) and Paul Hayes (right) at the NATROX® stand at EWMA 2018

Information for clinicians

Oxygen is critical to many of the processes required in wound healing. NATROX® Oxygen Wound Therapy allows you to prescribe topical oxygen in a very simple, safe and extremely convenient way directly to the wound bed.

Read more

Information for patients

NATROX® Oxygen Wound Therapy is a small portable device about the size of a mobile phone. Its function is to produce concentrated oxygen from the surrounding air, and pass this down a thin flexible tube directly to a wound that is failing to progress as expected.

Read more

Inotec AMD’s mission is to improve the quality of life for patients with chronic wounds by providing NATROX® an innovative topical oxygen therapy. Our culture is derived from a passion for medicine, compassion for patients, respect among employees and a commitment to all our internal and external customers.

Craig Kennedy CEO
Craig Kennedy